Nanobiotix Aktie
| 2,98EUR | -0,19EUR | -6,12% |
WKN DE: A1J7EB / ISIN: FR0011341205
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 97,29 |
| Invus Public Equities Advisors LLC | 12,40 |
| Edinburgh Worldwide Investment Trust Plc | 2,84 |
| Baillie Gifford Overseas Growth Fund - Global Discovery Fund | 2,64 |
| Laurent Lévy, PhD | 2,42 |
| Sycomore Fund SICAV - Europe Happy @ Work | 0,62 |
| Government Pension Fund - Global (The) | 0,53 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 110 | 90 | 100 | 102 | 102 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,29 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 46 | 125 | 93 | 52 | 87 |
| Summe Anlagevermögen | 10 | 9 | 9 | 7 | 7 |
| Summe Aktiva | 56 | 134 | 102 | 60 | 94 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 58 | 64 | 75 | 87 | 96 |
| Summe Eigenkapital | -2 | 70 | 27 | -27 | -2 |
| Summe Passiva | 56 | 134 | 102 | 60 | 94 |
Adresse
| 60, rue de Wattignies, 75012 Paris | |
| Telefon | +33 (1) 40-26-04-70 |
| Fax | +33 (1) 40-26-04-44 |
| Internet | http://www.nanobiotix.com |
Management
|
Alain Herrera
Member-Supervisory Board |
|
Anne-Juliette Hermant
Chief People Officer |
|
Anne-Marie Graffin
Deputy Chairman-Supervisory Board |
|
Bart van Rhijn
Chief Financial Officer |
|
Craig West
Senior Vice President-Investor Relations |
|
Enno Spillner
Member-Supervisory Board |
|
Gary M. Phillips
Chairman-Supervisory Board |
|
Laurent Lévy
Chairman-Executive Board & Chief Executive Officer |
|
Louis Kayitalire
Chief Medical Officer |
|
Margaret Galluzzi
Vice President & Head-Global Clinical Operations |
|
Patrick Tricoli
Global Head-Business Development |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
